Engineered for precise dosage uniformity, high bioavailability, and strict cGMP standard compliance across pharmaceutical, nutraceutical, and functional cosmetic industries.
Combining advanced European tablet compression hardware, comprehensive analytical chemistry labs, and cost-optimized supply chains to deliver unparalleled contract manufacturing value.
Equipped with ultra-high-speed rotary tablet presses featuring automatic weight control, multi-layer tableting abilities, and force-feeder systems for difficult botanical and synthetic powders.
Bilayer & EffervescentFully compliant with 21 CFR Part 111 and Part 117 standards. Facilities hold ISO 22000, SQF Edition 9, Halal, Kosher, and USDA Organic handling accreditations for global entry.
Audit-Ready DocumentationIn-house formulation scientists specialize in active ingredient micro-encapsulation, bitterness masking, tablet disintegration optimization, and taste engineering for chewable formats.
Custom FormulationsThe global dietary supplement and pharmaceutical tableting market is experiencing a structural transition toward clean-label formulations, modified-release kinetics, and multi-layer structural stability. As leading global brands seek enhanced product differentiation, contract development and manufacturing organizations (CDMOs) in China have upgraded from basic contract pressing to sophisticated formulation engineering platforms.
Achieving structural integrity while maintaining fast disintegration requires deep expertise in powder rheology and compaction physics. Direct Compression (DC) remains the gold standard for heat-sensitive actives (such as Vitamin C, Probiotics, and Botanical Extracts), minimizing moisture exposure and thermal degradation. However, for poorly compressible active pharmaceutical ingredients (APIs) or high-dose herbal powders, continuous fluid bed wet granulation is deployed to create uniform spherical granules with superior flowability and compactability.
| Granulation Methodology | Ideal Active Ingredients | Moisture & Thermal Impact | Friability Control Level | Production Throughput |
|---|---|---|---|---|
| Direct Compression (DC) | Vitamins, Minerals, Micro-encapsulated Oils | Zero Added Moisture / Ambient Temp | High (Dependent on Excipients) | Ultra-High (Up to 500,000 tabs/hr) |
| Fluid Bed Wet Granulation | High-Dose Botanical Extracts, Herbal Powders | Controlled Moisture / Low Heat Drying | Superior (< 0.5% Friability) | High (Batch Processed) |
| Roller Compaction (Dry Granulation) | Moisture-Sensitive Actives, Hygroscopic Extracts | No Water Used / Mechanical Pressure | Excellent Compression Profile | Continuous High Speed |
| Effervescent Matrix Compaction | Organic Acids + Bicarbonate Complexes | Dehumidified Climate Control (< 20% RH) | Extremely Precise Hardness Control | Specialized High Speed |
Bi-layer tableting technology allows CDMOs to combine incompatible active ingredients into a single monolithic dosage form. By separating reactive compounds into physically distinct layers, chemical stability is preserved without sacrificing patient compliance. Furthermore, modified-release profiles—such as sustained-release matrix tablets using Hydroxypropyl Methylcellulose (HPMC) or enteric-coated tablets designed for intestinal targeted dissolution—enable controlled kinetic release curves over 8 to 24-hour windows.
Modern consumers demand the elimination of synthetic binders and lubricants such as Magnesium Stearate, Titanium Dioxide, and Silicon Dioxide. In response, modern China tableting manufacturers utilize plant-derived functional excipients, including organic rice extract blends, acacia gum, native tapioca starches, and natural bamboo silica. These natural alternatives ensure smooth punch detachment, low friability, and rapid disintegration without compromising clean-label claim integrity.
Key shifts shaping how enterprise procurement directors, private label brands, and pharmaceutical buyers select CDMO partners in China.
Global brands are increasingly adopting global multi-region CDMO frameworks. By utilizing high-capacity China manufacturing hubs for raw material synthesis and high-speed tablet compression, combined with regional North American or European packaging hubs, procurement teams mitigate supply disruption risks while maintaining aggressive cost structures.
Regulatory bodies such as the US FDA, EFSA, and Amazon Health & Household Compliance require exhaustive analytical documentation. Procurement specifications now mandate full-spectrum lot testing including ICP-MS heavy metal panels, HPLC active assay verification, micro-bio pathogen testing, and 100% raw material FTIR identity checks.
Speed-to-market is the paramount driver of commercial success. Brands require CDMO partners capable of taking a concept from R&D benchtop prototype to pilot batch testing within 14 days, and full commercial-scale production within 8 to 12 weeks, accompanied by accelerated stability testing under ICH guidelines.
From raw powder characterization to final batch release, every step is executed inside controlled-environment cleanrooms under strict quality assurance supervision.
Excipient compatibility screening, powder particle size distribution (PSD) analysis, and moisture sorption isotherm mapping to determine ideal compression pathways.
High-shear wet granulation, fluid bed drying, or direct dry blending using V-blenders and Tote mixers to achieve uniform active dispersion (< 2% RSD).
Rotary tablet pressing with automated main and pre-compression force monitoring, followed by aqueous film coating or enteric coating in perforated pans.
Hardness, friability, thickness, disintegration, and dissolution profile validation in ISO-17025 accredited analytical laboratories prior to batch Certificate of Analysis issuance.
Detailed technical and commercial answers for sourcing managers, formula designers, and brand owners considering custom tablet manufacturing in China.
Our standard Minimum Order Quantity (MOQ) for custom tablet compression starts at 300,000 to 500,000 tablets per run for custom shapes, bi-layer formats, or specialized coatings. For standard round compressed tablets using established stock tooling, pilot batch sizes starting at 100,000 units can be accommodated. Bulk powder formulations or custom chewable chews start at 300 kg.
We provide a complete suite of functional and aesthetic tablet coating technologies, including:
Active ingredient uniformity is governed through rigorous process validation. We utilize state-of-the-art V-blenders and high-shear mixers equipped with near-infrared (NIR) sensors to monitor blend homogeneity in real-time. During compression, automated tablet presses continuously sample tablet weight, thickness, and hardness every 15 minutes, automatically adjusting main compression force to maintain tight active potency tolerances (±2.5% of target assay).
Every commercial batch is accompanied by a full export documentation package, including a comprehensive Certificate of Analysis (CoA) detailing physical parameters (hardness, friability, disintegration time, average weight), chemical active assay (HPLC/UV), heavy metal limits (ICP-MS for Lead, Cadmium, Mercury, Arsenic), micro-biological screening (TPC, Yeast & Mold, E. coli, Salmonella), and Allergen/Non-GMO declarations. Facility cGMP, ISO 22000, and FDA registration certificates are shared under Non-Disclosure Agreement (NDA).
Yes. Our in-house tooling engineers design custom punch dies for unique tablet geometries—including oval, capsule-shaped (caplets), triangle, heart, and custom brand logos or score-lines (break marks). Score-lines allow precise dose splitting for consumer convenience. Tooling design and steel die production typically require 2 to 3 weeks during initial R&D onboarding.
For existing validated formulations, standard lead time is 4 to 6 weeks for raw material sourcing, blending, compression, coating, and primary packaging. For new custom formulation development—including laboratory prototype samples, flavor testing, stability evaluation, and custom punch die manufacturing—total turnaround time ranges between 8 to 12 weeks to deliver fully market-ready finished goods.
Consult directly with our formulation engineering and procurement specialist team. We deliver custom formulation feedback, technical feasibility assessments, and comprehensive batch pricing quotes within 24 business hours.
